INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 108 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.68 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $74,000 | +42.3% | 13,320 | 0.0% | 0.01% | +37.5% |
Q2 2018 | $52,000 | -17.5% | 13,320 | 0.0% | 0.01% | -20.0% |
Q1 2018 | $63,000 | +14.5% | 13,320 | 0.0% | 0.01% | +11.1% |
Q4 2017 | $55,000 | -34.5% | 13,320 | 0.0% | 0.01% | -35.7% |
Q3 2017 | $84,000 | -19.2% | 13,320 | 0.0% | 0.01% | -22.2% |
Q2 2017 | $104,000 | +18.2% | 13,320 | 0.0% | 0.02% | +12.5% |
Q1 2017 | $88,000 | -4.3% | 13,320 | 0.0% | 0.02% | -11.1% |
Q4 2016 | $92,000 | -25.8% | 13,320 | 0.0% | 0.02% | -21.7% |
Q3 2016 | $124,000 | +0.8% | 13,320 | 0.0% | 0.02% | -4.2% |
Q2 2016 | $123,000 | +6.0% | 13,320 | 0.0% | 0.02% | +4.3% |
Q1 2016 | $116,000 | +28.9% | 13,320 | 0.0% | 0.02% | +27.8% |
Q4 2015 | $90,000 | +16.9% | 13,320 | 0.0% | 0.02% | +5.9% |
Q3 2015 | $77,000 | -29.4% | 13,320 | 0.0% | 0.02% | -26.1% |
Q2 2015 | $109,000 | 0.0% | 13,320 | 0.0% | 0.02% | +4.5% |
Q1 2015 | $109,000 | -10.7% | 13,320 | 0.0% | 0.02% | -4.3% |
Q4 2014 | $122,000 | -6.9% | 13,320 | 0.0% | 0.02% | -11.5% |
Q3 2014 | $131,000 | – | 13,320 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Triatomic Management LP | 235,000 | $405,000 | 0.23% |
Green Alpha Advisors, LLC | 147,380 | $254,000 | 0.22% |
Financial Advocates Investment Management | 14,161 | $628,000 | 0.05% |
Virtus ETF Advisers LLC | 72,540 | $125,000 | 0.05% |
Cedar Brook Financial Partners, LLC | 88,750 | $153,094 | 0.05% |
Rafferty Asset Management, LLC | 2,363,189 | $4,077,000 | 0.04% |
Hennion & Walsh Asset Management, Inc. | 352,721 | $608,000 | 0.04% |
CAXTON ASSOCIATES LP | 130,728 | $226,000 | 0.03% |
Keystone Financial Group | 74,058 | $128,000 | 0.03% |
Virtu Financial LLC | 130,829 | $226,000 | 0.02% |